Article History
First Online: 26 August 2020
Complaince with Ethical Standards
:
: Carmen de la Rocha and Gertrud Lund declare no conflict of interest. Dr. Zaina has a patent “Nanoparticle-based epigenome editing in atherosclerosis” pending to University of Guanajuato and a patent “Peptide-based epigenome editing in atherosclerosis” pending to University of Guanajuato.
: This article does not contain any studies with human or animal subjects performed by any of the authors.